Celsius Holdings, Inc.

CELH Details

Celsius Holdings, Inc. (NASDAQ: CELH) is engaged in the development, marketing, sale, and distribution of functional calorie-burning beverages. The company currently offers five beverage lines including Celsius® Originals, CelsiusHEAT ™, Celsius ® BCAA + Energy, Celsius ® On-the-Go and Celsius ®Sweetened with Stevia. The company has a market capitalization of ~$5.5 billion as on 2^nd June 2021.

Results Performance (Year Ended 31 December 2020)

Revenue of the company for the full-year period stood at around $130.7 million, an increase of 74.0% on the previous year. North America with 60% YoY increase in revenue to $95.5 million, contributed significantly to total revenue.  The balance of the increase was largely attributable to a 35% growth in European revenues to $33.7 million in 2020 from $14.5 million in 2019. Net income of the company for the year stood at $8.5 million, as compared to net income of $10.0 million in 2019.

Key Data (Source: Company Reports)

Results Performance (Q1FY21 Ended 31 March 2021)

Revenue growth in the period stood at $50.0 million, an increase of 78% YoY. North America contributed to about 90% of revenue growth having experienced 101% growth in revenue to $19.4 million over the prior quarter. The balance of the increase came from 22% growth in European revenues over the prior quarter to $10.4 million. Asian revenues increased 100% to $536K over the prior quarter, while other international markets generated $128K revenue from $57K in the previous quarter.

Outlook:

The company intends to use Func Food (acquired in October 2019) as a platform to expand product distribution elsewhere in Europe. Func Food was CELH’s Nordic distribution partner which markets products under its own brands. Further, it is closely monitoring the COVID-19 pandemic and its potential impact on its supply chain, distribution and consolidated results of operations.

Key Risks:

The company’s business and results of operations may be adversely affected by changes in the global macro-economic environment which may also include the negative impacts from the pandemic.

Valuation Methodology: EV/Sales Multiple Based Relative Valuation (Illustrative)

Technical Overview:

Weekly Chart –

Source: Refinitiv (Thomson Reuters)

Note: Purple colour lines are Bollinger Bands® with the upper band suggesting overbought status while the lower band oversold status, and yellow lines are Fibonacci retracement lines which measure price rebound and backtrack. https://www.bollingerbands.com/

The stock having experienced a smooth ride, it has been experiencing uneven ride, lately. However, in the process, it has managed to make a new high. The technical indicator RSI with a reading around 69, suggests that the stock is near the overbought zone, thereby, limiting the potential for the upside.

Going forward, the stock may have resistance around $80.73 whereas support could be around $65.00.

Stock Recommendation:

The company’s gross margin and EBITDA margin improved from 41.7% and -0.7% in FY19 to 46.6% and 6.8% in FY20, respectively. However, its net margin for FY20 stood at 6.5%, lower than the industry median of 10.1%. ROE for FY20 stood at 10.2%, lower than the industry median of 15.5%.

Considering the lower ROE that the company generated in FY20 and the lingering of the pandemic, it is advisable for investors to book profits at the current level.

We have applied EV/Sales multiple-based relative valuation (on an illustrative basis) and there are expectations that the stock price might witness a fall of low double-digit (in % terms). We have applied a slight discount to EV/Sales Multiple (NTM) (Peer Average) considering lower ROE and gross margin as well as the risks associated.

The stock rose by ~284.4% in 9 months. It has made a 52-week low and high of $8.51 and $70.66, respectively. Considering the movement in the stock price, it looks like most of the positive developments have been discounted in the current price.

Hence, we give a “Sell” recommendation on the stock at the current market price of $76.47 per share, up by 15.04% on 2^nd June 2021.

Note 1: The reference data in this report has been partly sourced from REFINITIV.

Note 2: Investment decisions should be made depending on the investors’ appetite on upside potential, risks, holding duration, and any previous holdings. Investors can consider exiting from the stock if the Target Price mentioned as per the analysis has been achieved and subject to the factors discussed above alongside support levels provided.

Technical Indicators Defined:-

Support: A level where-in the stock prices tend to find support if they are falling, and downtrend may take a pause backed by demand or buying interest.

Resistance: A level where-in the stock prices tend to find resistance when they are rising, and uptrend may take a pause due to profit booking or selling interest.

Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.